Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bander

Showing results (611-620 of 700) with videos related to

Pageof 70
Sort By:
Diagnostics (Basel, Switzerland)|February 25, 2023
Procedural Software Toolkit in the Armamentarium of Interventional Therapies: A Review of Additive Usefulness and Current EvidenceAbdulaziz M Al-Sharydah, Faisal Khalid BinShaiq, Rayan Ibrahim Aloraifi, et al.
Molecular Cancer Therapeutics|June 13, 2018
Anti-PSMA/CD3 Bispecific Antibody Delivery and Antitumor Activity Using a Polymeric Depot FormulationWilhem Leconet, He Liu, Ming Guo, et al.
Urologic Oncology|October 22, 2016
Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancerMatthew I Milowsky, Matthew D Galsky, Michael J Morris, et al.
The Journal of Emergency Medicine|February 9, 2024
Body Core Temperature Assessment in Emergency Care DepartmentsHein A M Daanen, Gercora Hoitinga, David J Kruijt, et al.
The Oncologist|January 31, 2020
Pilot Study of Hyperfractionated Dosing of Lutetium-177-Labeled Antiprostate-Specific Membrane Antigen Monoclonal Antibody J591 (<sup>177</sup> Lu-J591) for Metastatic Castration-Resistant Prostate CancerMuhammad Junaid Niaz, Jaspreet S Batra, Ryan D Walsh, et al.
Molecular Urology|November 4, 2000
Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapyM C Gong, S S Chang, F Watt, et al.
Cost Effectiveness and Resource Allocation : C/E|December 13, 2019
Drug utilization and cost associated with inflammatory bowel disease management in Saudi ArabiaYazed AlRuthia, Othman Alharbi, Abdulrahman M Aljebreen, et al.
Environmental Pollution (Barking, Essex : 1987)|August 26, 2021
Molybdenum and hydrogen sulfide synergistically mitigate arsenic toxicity by modulating defense system, nitrogen and cysteine assimilation in faba bean (Vicia faba L.) seedlingsManzer H Siddiqui, Saud Alamri, Soumya Mukherjee, et al.
Biogerontology|March 30, 2025
Exploring TGF-β signaling in benign prostatic hyperplasia: from cellular senescence to fibrosis and therapeutic implicationsAbida Khan, Hayat Ali Alzahrani, Shatha Ghazi Felemban, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 19, 2010
Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiencyHamoud Al-Mousa, Zamil Al-Shammari, Abdulaziz Al-Ghonaium, et al.
Pageof 70

Showing results (611-620 of 700) with videos related to

Sort By:
Pageof 70
Diagnostics (Basel, Switzerland)|February 25, 2023
Procedural Software Toolkit in the Armamentarium of Interventional Therapies: A Review of Additive Usefulness and Current EvidenceAbdulaziz M Al-Sharydah, Faisal Khalid BinShaiq, Rayan Ibrahim Aloraifi, et al.
Molecular Cancer Therapeutics|June 13, 2018
Anti-PSMA/CD3 Bispecific Antibody Delivery and Antitumor Activity Using a Polymeric Depot FormulationWilhem Leconet, He Liu, Ming Guo, et al.
Urologic Oncology|October 22, 2016
Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancerMatthew I Milowsky, Matthew D Galsky, Michael J Morris, et al.
The Journal of Emergency Medicine|February 9, 2024
Body Core Temperature Assessment in Emergency Care DepartmentsHein A M Daanen, Gercora Hoitinga, David J Kruijt, et al.
The Oncologist|January 31, 2020
Pilot Study of Hyperfractionated Dosing of Lutetium-177-Labeled Antiprostate-Specific Membrane Antigen Monoclonal Antibody J591 (<sup>177</sup> Lu-J591) for Metastatic Castration-Resistant Prostate CancerMuhammad Junaid Niaz, Jaspreet S Batra, Ryan D Walsh, et al.
Molecular Urology|November 4, 2000
Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapyM C Gong, S S Chang, F Watt, et al.
Cost Effectiveness and Resource Allocation : C/E|December 13, 2019
Drug utilization and cost associated with inflammatory bowel disease management in Saudi ArabiaYazed AlRuthia, Othman Alharbi, Abdulrahman M Aljebreen, et al.
Environmental Pollution (Barking, Essex : 1987)|August 26, 2021
Molybdenum and hydrogen sulfide synergistically mitigate arsenic toxicity by modulating defense system, nitrogen and cysteine assimilation in faba bean (Vicia faba L.) seedlingsManzer H Siddiqui, Saud Alamri, Soumya Mukherjee, et al.
Biogerontology|March 30, 2025
Exploring TGF-β signaling in benign prostatic hyperplasia: from cellular senescence to fibrosis and therapeutic implicationsAbida Khan, Hayat Ali Alzahrani, Shatha Ghazi Felemban, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 19, 2010
Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiencyHamoud Al-Mousa, Zamil Al-Shammari, Abdulaziz Al-Ghonaium, et al.
Pageof 70